Search

Rare genetic differences increase a person’s risk of serious heart problems and sudden cardiac death even in the absence of symptoms, according to research we've funded and presented at the European Society of Cardiology Congress.

RESEARCH

University of Leicester | Professor Nicholas Brindle

Professor Nicholas Brindle and his team at the University of Leicester are investigating an unusual new way to try and treat heart and circulatory disease. Angiopoietin 2, or Ang2, is a protein that is normally produced at very low leve...

RESEARCH

Imperial College London | Dr Gregory Quinlan

Eisenmenger syndrome (ES) is a rare complication of a congenital heart defect, which causes increased blood pressure in the arteries of the lungs, known as pulmonary arterial hypertension (PAH). Recent research has suggested that problems w...

RESEARCH

University College London | Professor Andrew Taylor

In the UK, 12 babies a day are diagnosed with a congenital heart defect, a condition or defect that develops in the womb before a baby is born. The defects seen in babies’ hearts are numerous, complex and often unique. It is now possible to...

RESEARCH

University of Oxford | Dr Michael Holmes

Although research has revealed the main causes of heart disease, there is still much detail we don’t know. In this fellowship, Dr Holmes intends to analyse the blood in intricate detail to determine whether certain molecules and processes c...

Study suggests extra virgin olive oil could cut heart disease risk.

RESEARCH

University of Cambridge | Professor John Danesh

The British Heart Foundation is funding BHF Professor John Danesh, at the University of Cambridge, nearly £2 million over five years to create an international group of heart experts. This group will bring together data from around the worl...

RESEARCH

University of Reading | Professor Jian-Mei Li

Evidence is emerging that an enzyme called NADPH oxidase 2 (Nox2) is involved in blood vessel wall damage, high blood pressure, and aneurysms by producing harmful molecules called oxidants. Targeting Nox2 could be a way of treating these di...

We want to beat heartbreak caused by heart and circulatory diseases in Wales. To do this, we need to improve the detection, diagnosis, treatment and care of people who develop a heart or circulatory condition in their lifetime